Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

There was no correlation between mGFR and serum potassium.Hypokalemia was due to a nonreabsorbable anion effect of methylmalonate. a Urinary potassium (mmol/mmol of creatininuria) was positively associated with urinary methylmalonate (µmol/mmol of creatininuria), R = 0.77, p = 0.004. b Serum potassium (mmol/L) was negatively associated with urinary methylmalonate (µmol/mmol of creatininuria), R = − 0.61, p = 0.03Biological resultsMedianMin: MaxStandardsMeasured GFR (mL/min/1.73 m2)56.523 to 105> 90Estimated GFR by Schwartz formula (mL/min/1.73 m2)7726 to 123> 90Estimated GFR by CKD-EPI (mL/min/1.73 m2)11231 to 144> 90Serum laboratory dataUrea (mmol/L)3.82.4 to 8.12.5 to 8.0Sodium (mmol/L)138135 to 141136 to 146Potassium (mmol/L)3.82.8 to 4.73.5 to 4.5Chloride (mmol/L)105100 to 10898 to 107Uric acid (µmol/L)421202 to 703150 to 350Magnesium (mmol/L)0.830.68 to 0.960.85 to 1.15Alkaline reserve (mmol/L)2522.3 to 3022 to 29Total calcium (mmol/L)2.32.2 to 2.62.25 to 2.6Ionized calcium (mmol/L)1.171.13 to 1.241.15 to 1.34Phosphorus (mmol/L)1.00.79 to 1.40.85 to 1.5PTH (pg/mL)47.228.9 to 106.610 to 5025OH vitamin D (ng/mL)2815 to 7630 to 801 to 25 OH vitamin D (pg/mL)4323 to 10630 to 60Urinary parametersFractional excretion of sodium (%)1.10.2 to 7.0NAPotassium (mmol/L)47.513.4 to 118NAFractional excretion of potassium (%)20.85.7 to 63.9NACalcium (mmol/L)0.50.5 to 2.77 < 3.6Calcium (mmol/mmol)**0.070.02 to 0.28 < 0.55Fractional excretion of calcium (%)1.80.5 to 4.1NAFractional excretion of urea (%)5.10.04 to 12.2NAFractional excretion of phosphate (%)9.61.5 to 48.6NAFractional excretion of magnesium (%)4.92.0 to 11.3NATmP-GFR (mmol/L)*0.90.5 to 1.40.7 to 1.4Proteinuria (mg/mmol)**8.50 to 34.6 < 50Microalbuminuria (mg/mmol)**0.80 to 15.4 < 35β2-microglobulinuria (µg/mmol)**6.00 to 506 < 35GFR, glomerular filtration rate; NA, non-applicable; TmP-GFR, tubular maximum reabsorption capacity of phosphate*Urinary analytes per mmol of urinary creatinine**mGFR was used to calculate TmP-GFR

Source: Potassium. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were asked to drink 400 mL of water for 30 min after injection of iohexol, then 150 mL per hour from the second hour to the end of the test.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Long-term renal outcome in methylmalonic acidemia in adolescents and adults

Study design awaiting verification · Orphanet Journal of Rare Diseases · 2021

Original publication title

Long-term renal outcome in methylmalonic acidemia in adolescents and adults

Myriam Dao; Jean-Baptiste Arnoux; Frank Bienaimé; Anaïs Brassier; François Brazier; Jean-François Benoist; Clément Pontoizeau; Chris Ottolenghi; Pauline Krug; Olivia Boyer; Pascale de Lonlay; Aude Servais

© The Author(s) 2021

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

CKD is a common complication of the MMA. Usual equations overestimate GFR. Therefore, mGFR should be performed to inform therapeutic decisions such as dialysis and/or transplantation. Mild evidence of proximal tubular dysfunction was found in only one patient, suggesting that other mechanisms are involved.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Chronic kidney disease (CKD) is one of the main long-term prognosis factors in methylmalonic acidemia (MMA), a rare disease of propionate catabolism. Our objective was to precisely address the clinical and biological characteristics of long-term CKD in MMA adolescent and adult patients.

Source: Background

Abstract: What methods does the paper describe?

In this retrospective study, we included MMA patients older than 13 years who had not received kidney and/or liver transplantation. We explored tubular functions, with special attention to proximal tubular function. We measured glomerular filtration rate (mGFR) by iohexol clearance and compared it to estimated glomerular filtration rate (eGFR) by Schwartz formula and CKD-EPI.

Source: Patients and methods

Abstract: Results

Thirteen patients were included (M/F = 5/8). Median age was 24 years (13 to 32). Median mGFR was 57 mL/min/1.73 m2 (23.3 to 105 mL/min/1.73 m2). Ten out of 13 patients had mGFR below 90 mL/min/1.73 m2. No patient had significant glomerular proteinuria. No patient had complete Fanconi syndrome. Only one patient had biological signs suggestive of incomplete proximal tubulopathy. Four out of 13 patients had isolated potassium loss, related to a non-reabsorbable anion effect of urinary methylmalonate.

Both Schwartz formula and CKD-EPI significantly overestimated GFR. Bias were respectively 16 ± 15 mL/min/1.73 m2 and 37 ± 22 mL/min/1.73 m2.

Source: Results

Abstract: Conclusion

CKD is a common complication of the MMA. Usual equations overestimate GFR. Therefore, mGFR should be performed to inform therapeutic decisions such as dialysis and/or transplantation. Mild evidence of proximal tubular dysfunction was found in only one patient, suggesting that other mechanisms are involved.

Source: Conclusion
Authors’ abstract

Background

Chronic kidney disease (CKD) is one of the main long-term prognosis factors in methylmalonic acidemia (MMA), a rare disease of propionate catabolism. Our objective was to precisely address the clinical and biological characteristics of long-term CKD in MMA adolescent and adult patients.

Patients and methods

In this retrospective study, we included MMA patients older than 13 years who had not received kidney and/or liver transplantation. We explored tubular functions, with special attention to proximal tubular function. We measured glomerular filtration rate (mGFR) by iohexol clearance and compared it to estimated glomerular filtration rate (eGFR) by Schwartz formula and CKD-EPI.

Results

Thirteen patients were included (M/F = 5/8). Median age was 24 years (13 to 32). Median mGFR was 57 mL/min/1.73 m2 (23.3 to 105 mL/min/1.73 m2). Ten out of 13 patients had mGFR below 90 mL/min/1.73 m2. No patient had significant glomerular proteinuria. No patient had complete Fanconi syndrome. Only one patient had biological signs suggestive of incomplete proximal tubulopathy. Four out of 13 patients had isolated potassium loss, related to a non-reabsorbable anion effect of urinary methylmalonate.

Both Schwartz formula and CKD-EPI significantly overestimated GFR. Bias were respectively 16 ± 15 mL/min/1.73 m2 and 37 ± 22 mL/min/1.73 m2.

Conclusion

CKD is a common complication of the MMA. Usual equations overestimate GFR. Therefore, mGFR should be performed to inform therapeutic decisions such as dialysis and/or transplantation. Mild evidence of proximal tubular dysfunction was found in only one patient, suggesting that other mechanisms are involved.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13023-021-01851-z.

Publication and source details

Original title: Long-term renal outcome in methylmalonic acidemia in adolescents and adults

Myriam Dao; Jean-Baptiste Arnoux; Frank Bienaimé; Anaïs Brassier; François Brazier; Jean-François Benoist; Clément Pontoizeau; Chris Ottolenghi; Pauline Krug; Olivia Boyer; Pascale de Lonlay; Aude Servais

Orphanet Journal of Rare Diseases · 2021

© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T12:42:38.658199+00:00

DOI: 10.1186/s13023-021-01851-z · PMC8120835